Onco-Innovations Limited
ONNVF
$0.78
$0.0913.32%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 87.60K | 110.60K | 60.20K | 46.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.60K | 110.60K | 60.20K | 46.00K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 87.60K | 87.60K | 37.20K | 23.00K | -- |
| SG&A Expenses | 4.80M | 4.28M | 2.37M | 2.06M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.62M | 4.95M | 2.74M | 2.25M | -- |
| Operating Income | -5.54M | -4.86M | -2.70M | -2.23M | -- |
| Income Before Tax | -9.58M | -9.02M | -6.55M | -4.85M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.58 | -9.02 | -6.55 | -4.85 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.58M | -9.02M | -6.55M | -4.85M | -- |
| EBIT | -5.54M | -4.86M | -2.70M | -2.23M | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.21 | -0.21 | -0.17 | -0.14 | -- |
| Normalized Basic EPS | -0.11 | -0.11 | -0.08 | -0.06 | -- |
| EPS Diluted | -0.21 | -0.21 | -0.17 | -0.14 | -- |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.08 | -0.06 | -- |
| Average Basic Shares Outstanding | 197.23M | 180.42M | 164.47M | 145.57M | -- |
| Average Diluted Shares Outstanding | 197.23M | 180.42M | 164.47M | 145.57M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |